Research organisation profile: The Garvan Institute of Medical Research

The Garvan Institute of Medical Research brings together world-leading basic and translational researchers with expert clinicians. We are patient focused. Our researchers break down barriers between traditional scientific disciplines to find solutions to disease. Garvan’s researchers have made significant advances in genome, epigenome, protein and cell analysis technology. We have revealed causes and treatments for diseases including diabetes, osteoporosis, cancer, immune deficiency and autoimmunity.

Today, Garvan’s mission builds on those advances, harnessing all the information encoded in our DNA to better diagnose, treat, predict and prevent disease. Most diseases have a genetic component — from rare, genetic disorders to complex diseases such as cancer, diabetes and autoimmunity. That’s why we study the underlying genetic causes and drivers of these diseases.

Garvan’s goal is to translate discovery into meaningful health benefits for those living with disease and their family. Patients, clinical trial cohorts and population cohorts are at the centre of Garvan’s research. We are focused on addressing the unmet needs of those living with disease – where better understanding, new treatments and more effective diagnosis can have the biggest impact.

The Kinghorn Centre for Clinical Genomics is one of Garvan’s leading research centres, focused on accelerating and translating discoveries to benefit patients. Its research and implementation groups focus on informatics, new technologies, informatics, clinical translation and education. KCCG works with alliances and research organisations worldwide to enable valuable translational research.

Through cutting-edge technology, facilities, local and international collaborations, Garvan researchers strive, every day, to create a future where everyone lives longer, healthier lives.  


*For more information about The Garvan Institute of Medical Research, visit their official website.